Below are the members of our Board in 2018 and 2019, along with their profiles. All of the Non-Executive Directors meet the definition of independent directors as provided by the UK Corporate Governance Code (as annotated for Mutual Insurers).
William Wallace Dobbin BA, Barrister
Appointment to the Board: Wallace Dobbin was appointed to the Board in March 2008 and became its Chairman in June 2013.
Committee Membership: Member of the Nomination Committee and the Remuneration Committee. Wallace attends other committees by invitation.
Experience and other directorships: Wallace has extensive experience in corporate strategy, marketing and communications and is a trained lawyer. Previous roles include being a member of the UK Board of Zurich Financial Services, Strategic Development Director for BAT UK Financial Services and Business Development Director for Allied Dunbar Assurance.
Wallace is a Non-Executive Director of Intrinsic Financial Services Ltd, one of the UK’s largest financial services distribution companies and was formerly Vice Chairman and Senior Independent Director of the Gloucestershire Hospitals NHS Foundation Trust. He is a member of the Council of the Association of Professional Financial Advisers, a former member of the CBI London Council and a former Trustee of the Sir Steve Redgrave Charitable Trust.
David Brand BA, FIA
Senior Independent Director (Non-Executive)
Appointment to the Board: David was appointed to the Board as Senior Independent Director from January 2014.
Committee Membership: Chairman of the Audit Committee and Investment Committee and a member of the Governance and Risk Committee, the Nomination Committee and the Remuneration Committee.
Experience and other directorships: David is a qualified actuary who, prior to his retirement in June 2012, had worked for the Hannover Re Group in the UK, acting as the Managing Director of its UK life reinsurance subsidiary from 2003. David had been with the company since 1988, and a Director since 1990. During his career David also held various roles with the Institute of Actuaries, including being a member of Council and he also served on the Health Committee of the Association of British Insurers from 2006 to 2012.
David is an independent Non-Executive Director of Chesnara Plc, the life and pensions management company, where he also serves on the Audit and Risk Committee, Remuneration Committee and the Nomination Committee. He is an independent Non-Executive Director of Chesnara’s life insurance subsidiaries, Countrywide Assured in the UK and Movestic Liv in Sweden, where he is the Chairman of the Audit and Risk Committee.
Helen McEwan BA, AFPC
Independent Non-Executive Director
Appointment to the Board: Helen was appointed to the Board in September 2016.
Committee Membership: Chairman of the Nomination Committee and is also a member of the Audit Committee, the Governance and Risk Committee, the Investment Committee and the Remuneration Committee.
Experience and other directorships: Helen has a wealth of experience across the financial services arena with particular expertise in leadership and distribution across all channels. Helen spent many successful years at Aegon UK (a global financial services insurer), where her roles included Director of Banks, Partnerships Director and Head of International Sales. During her tenure, Helen was highly regarded for her astute commercial acumen coupled with her ability to develop key distribution partnerships, optimise new business volume and nurture new talent.
Since leaving Aegon, Helen has held roles with Fintech Adviser firm, True Potential as Commercial Director and as Business Development Director with Auto-enrolment specialist, Now Pensions.
Helen is also Trustee of Edinburgh Young Careers, a charity dedicated to improving the quality of the lives of children (from age 5-19) who have caring responsibilities in their homes.
Stephen Payne BSc, FIA
Independent Non-Executive Director
Appointment to the Board: Steve was appointed to the Board in September 2015.
Committee Membership: Chairman of the Governance and Risk Committee and the Remuneration Committee and is also a member of the Audit Committee, the Investment Committee and the Nomination Committee.
Experience and other directorships: Steve is a qualified Actuary who has held a variety of senior management roles in the Life Assurance industry. These include Managing Director for Protection at Friends Life (2011-2014), a FTSE100 company, where he led the integration of the protection businesses of AXA, Friends Provident and Bupa. Steve was a member of Friends Life’s Group Executive. Prior to this, he led the Bupa Protection business where he became Chief Executive (2004-2010).
Steve is an independent Non-Executive Director of Pacific Life Re Limited, the life reinsurance company.
Steve has also worked for two Reassurance businesses which are now known as Scor and Hannover Re, and was Deputy Chief Executive at Revios (UK), the company that became Scor (UK) (2004).
Steve is a past Chair of ILAG (The Investment and Life Assurance Group), a former member of the ABI Protection Committee, and was twice chair of the Institute and Faculty of Actuaries Healthcare Conference.
Andrew Chapman ACII, APFS
Appointment to the Board: Andy Chapman was appointed Chief Executive in March 2008, following the transfer of engagements from Pioneer Friendly Society, having been the Chief Executive at Pioneer since September 2005. He joined Pioneer having previously been Group Director at Liverpool Victoria Friendly Society and Managing Director at Permanent Insurance.
Committee Membership: Member of the Investment Committee.
Experience and other directorships: Andy was appointed to the Board of the Association of Financial Mutuals (AFM), the trade body which represents mutual insurers, friendly societies and other financial mutuals in the UK and in 2016 was appointed Chairman of the AFM. In 2017, Andy was appointed to the Financial Conduct Authority Smaller Business Practitioner Panel. The Panel represents the interests of practitioners of firms of small or medium size within their sector across the range of regulated activities as regulated by the FCA. He also sits on the Health Committee of the Association of British Insurers (ABI). The ABI is the voice of insurance, representing the general insurance, investment and long-term savings industry.
He is currently a Trustee of the Northbrook Trust, a charity set up to fund the provision of education and training (including support and accommodation) for any child or young person who is, or has been, in the care of or under the supervision of Devon County Council.
Paul Austin BSc, FCA
Appointment to the Board: Paul Austin was appointed Finance Director in February 2009.
Committee Membership: Member of the Governance and Risk Committee.
Experience and other directorships: Paul has spent his entire career within the financial services sector in both professional accountancy practice and industry. After qualifying with PricewaterhouseCoopers in 1989, he gained experience of corporate lending, fund management and for 12 years worked with a fully-listed group running a provider of financial services outsourcing services.
In addition to these technical roles, Paul’s past duties have included Group Operations, Human Resources and Information Technology, as well as Board involvement in the assessment and implementation of strategy, mergers and acquisitions.
Steve Bryan BA
Director of Distribution and Marketing
Appointment to the Board: Steve Bryan was appointed Director of Distribution and Marketing in July 2017.
Experience and other directorships: Steve has spent his entire career in Financial Services, joining Lloyds Bank immediately on graduation from the University of Leeds. Prior to joining The Exeter, Steve had a distinguished 20-year tenure with Legal & General. His last role saw him head up the Intermediary division for Legal & General Insurance, responsible for leading Legal & General's Intermediary distribution in both the protection and GI markets. He brings a wealth of experience across the protection, mortgage and healthcare markets.
In his role with The Exeter, Steve has responsibility for the sales, marketing and product development teams.
Professor William Hamilton CBE, MD, BSc, FRCP, FRCGP
Appointment to the Board: Willie Hamilton, an insurance medical officer since 1990, joined The Exeter Board in 2005.
Experience and other directorships: He qualified in medicine in 1982, and has a research career on improving diagnosis, particularly that of cancer. He is the professor of Primary Care Diagnostics at the University of Exeter Medical School, where he heads the Discovery research group, with over £35 million total research funding, and over 250 publications. His main research topic is improving the diagnosis of cancer, both by identifying which patients are most at risk, and now studying which tests are the best to offer.
Willie has received a number of accolades during his distinguished career. He has won Research Paper of the Year twice. He has also written two textbooks, one on orthopaedics and the second on cancer, the latter winning a British Medical Association prize. He was the clinical lead for a NICE (National Institute for Health and Care Excellence) guideline NG12, on investigation of suspected cancer. He was awarded a CBE in the 2019 New Years’ Honours list for 'services to improving early cancer diagnosis'.